BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 29452147)

  • 1. Combination of Kras activation and PTEN deletion contributes to murine hepatopancreatic ductal malignancy.
    Lin YK; Fang Z; Jiang TY; Wan ZH; Pan YF; Ma YH; Shi YY; Tan YX; Dong LW; Zhang YJ; Wang HY
    Cancer Lett; 2018 May; 421():161-169. PubMed ID: 29452147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN loss and KRAS activation cooperate in murine biliary tract malignancies.
    Marsh V; Davies EJ; Williams GT; Clarke AR
    J Pathol; 2013 Jun; 230(2):165-73. PubMed ID: 23483557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion.
    Ikenoue T; Terakado Y; Nakagawa H; Hikiba Y; Fujii T; Matsubara D; Noguchi R; Zhu C; Yamamoto K; Kudo Y; Asaoka Y; Yamaguchi K; Ijichi H; Tateishi K; Fukushima N; Maeda S; Koike K; Furukawa Y
    Sci Rep; 2016 Apr; 6():23899. PubMed ID: 27032374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN.
    Chen WT; Zhu G; Pfaffenbach K; Kanel G; Stiles B; Lee AS
    Oncogene; 2014 Oct; 33(42):4997-5005. PubMed ID: 24141775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice.
    Yang Y; Wang J; Wan J; Cheng Q; Cheng Z; Zhou X; Wang O; Shi K; Wang L; Wang B; Zhu X; Chen J; Feng D; Liu Y; Jahan-Mihan Y; Haddock AN; Edenfield BH; Peng G; Hohenstein JD; McCabe CE; O'Brien DR; Wang C; Ilyas SI; Jiang L; Torbenson MS; Wang H; Nakhleh RE; Shi X; Wang Y; Bi Y; Gores GJ; Patel T; Ji B
    J Hepatol; 2024 Jul; 81(1):120-134. PubMed ID: 38428643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas.
    Hsu M; Sasaki M; Igarashi S; Sato Y; Nakanuma Y
    Cancer; 2013 May; 119(9):1669-74. PubMed ID: 23335286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
    Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
    J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma.
    Tuveson DA; Zhu L; Gopinathan A; Willis NA; Kachatrian L; Grochow R; Pin CL; Mitin NY; Taparowsky EJ; Gimotty PA; Hruban RH; Jacks T; Konieczny SF
    Cancer Res; 2006 Jan; 66(1):242-7. PubMed ID: 16397237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation of SOX9
    Chen J; Debebe A; Zeng N; Kopp J; He L; Sander M; Stiles BL
    Sci Rep; 2021 Jun; 11(1):11823. PubMed ID: 34083580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial-to-mesenchymal transition in ovarian cancer.
    Zhang L; Ma T; Brozick J; Babalola K; Budiu R; Tseng G; Vlad AM
    Oncogene; 2016 Sep; 35(38):5010-20. PubMed ID: 26973247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic action of Smad4 and Pten in suppressing pancreatic ductal adenocarcinoma formation in mice.
    Xu X; Ehdaie B; Ohara N; Yoshino T; Deng CX
    Oncogene; 2010 Feb; 29(5):674-86. PubMed ID: 19901970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.
    Qiu W; Tang SM; Lee S; Turk AT; Sireci AN; Qiu A; Rose C; Xie C; Kitajewski J; Wen HJ; Crawford HC; Sims PA; Hruban RH; Remotti HE; Su GH
    Gastroenterology; 2016 Jan; 150(1):218-228.e12. PubMed ID: 26408346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear BAP1 loss is common in intrahepatic cholangiocarcinoma and a subtype of hepatocellular carcinoma but rare in pancreatic ductal adenocarcinoma.
    Mosbeh A; Halfawy K; Abdel-Mageed WS; Sweed D; Rahman MHA
    Cancer Genet; 2018 Aug; 224-225():21-28. PubMed ID: 29778232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kras, Pten, NF-κB, and inflammation: dangerous liaisons.
    Chiao PJ; Ling J
    Cancer Discov; 2011 Jul; 1(2):103-5. PubMed ID: 22586351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
    Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
    Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma.
    Marcus R; Ferri-Borgogno S; Hosein A; Foo WC; Ghosh B; Zhao J; Rajapakshe K; Brugarolas J; Maitra A; Gupta S
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
    Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
    Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutation analysis of KRAS, BRAF, HER2 and PTEN in EGFR mutation-negative non-small cell lung carcinoma: determination of frequency, distribution pattern and identification of novel deletion in HER2 gene from Indian patients.
    Bhaumik S; Ahmad F; Das BR
    Med Oncol; 2016 Oct; 33(10):117. PubMed ID: 27637917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC1 positive, Kras and Pten driven mouse gynecologic tumors replicate human tumors and vary in survival and nuclear grade based on anatomical location.
    Tirodkar TS; Budiu RA; Elishaev E; Zhang L; Mony JT; Brozick J; Edwards RP; Vlad AM
    PLoS One; 2014; 9(7):e102409. PubMed ID: 25078979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
    Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP
    Cancer Res; 2003 May; 63(9):2016-9. PubMed ID: 12727811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.